Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis of Nirmatrelvir: Development of an Efficient, Scalable Process to Generate the Western Fragment
Russell F. Algera, Christophe Allais, Aaron F. Baldwin, et al.
Organic Process Research & Development (2023) Vol. 27, Iss. 12, pp. 2240-2249
Open Access | Times Cited: 11

Showing 11 citing articles:

Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions
Ahmed M. Shawky, Faisal A. Almalki, Hayat Ali Alzahrani, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116704-116704
Closed Access | Times Cited: 5
Synthesis of Nirmatrelvir: Development of a Scalable Cobalt-Catalyzed Cyclopropanation for Manufacture of the Bicyclic [3.1.0]Proline-Building Block
Russell F. Algera, Christophe Allais, Aaron F. Baldwin, et al.
Organic Process Research & Development (2023) Vol. 27, Iss. 12, pp. 2260-2270
Closed Access | Times Cited: 12
Synthesis of Nirmatrelvir: Design and Optimization of an Efficient Telescoped Amidation–Dehydration Sequence
Russell F. Algera, Aaron F. Baldwin, Paul Bowles, et al.
Organic Process Research & Development (2023) Vol. 27, Iss. 12, pp. 2250-2259
Closed Access | Times Cited: 11
Synthesis of Nirmatrelvir: Development of Magnesium Sulfate-Mediated Aminolysis for the Manufacture of the Eastern Fragment
Russell F. Algera, Christophe Allais, Husein Becirovic, et al.
Organic Process Research & Development (2023) Vol. 27, Iss. 12, pp. 2271-2279
Closed Access | Times Cited: 11
Development with greenness evaluation and validation of stability indicating ion-pair reverse phase HPLC method for determination of related substances and assay of Nirmatrelvir drug substance
Sonali Mehendale-Munj, Manoj A. Mangukiya, Aman A. Desai, et al.
Analytical Chemistry Letters (2025) Vol. 15, Iss. 1, pp. 65-82
Closed Access
Development of New Catalytic Asymmetric Routes towards a Cost-Driving Building Block of Nirmatrelvir
Robert Szpera, Shanjun Huang, Harriet A. M. Fenton, et al.
(2024)
Open Access | Times Cited: 2
Reducing the cost of making drugs for low/limited-income countries by going green
Bruce H. Lipshutz
Trends in Chemistry (2024) Vol. 6, Iss. 4, pp. 173-185
Open Access | Times Cited: 2
Nirmatrelvir: From Discovery to Modern and Alternative Synthetic Approaches
Michela Galli, Francesco Migliano, Valerio Fasano, et al.
Processes (2024) Vol. 12, Iss. 6, pp. 1242-1242
Open Access | Times Cited: 2
Development of New Catalytic Asymmetric Routes toward a Cost-Driving Building Block of Nirmatrelvir
Robert Szpera, Shanjun Huang, Harriet A. M. Fenton, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 7, pp. 2743-2754
Closed Access
Building and Evolving a Chiral Control Strategy for Accelerated COVID Programs
Christophe Allais, Aaron F. Baldwin, Hugh J. Clarke, et al.
Organic Process Research & Development (2024)
Closed Access
Recent Advances in Nonprecious Metal Catalysis
David J. Bernhardson, Aran K. Hubbell, Robert A. Singer, et al.
Organic Process Research & Development (2024)
Closed Access
Page 1

Scroll to top